BHP Seeks Extension For Takeover; GoldMining Begins São Jorge Drilling; Ivanhoe Electric Advances Copper Project And More: Wednesday's Top Mining Stories
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and
GlycoMimetics, Inc. (NASDAQ:GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that it will host a key opinion
UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bernstein 40th Annual Strategic Decisions Conference.